Successful Third Year Field Trial of Evogene Ltd.'s Candidate Gene for Improving Yield and Abiotic Stress Tolerance

REHOVOT, ISRAEL--(Marketwire - December 19, 2007) - Evogene Ltd. (TELAVIV: EVGN) today announced successful third year field trial results for Evo133, one of its candidate genes for improving plant yield and tolerance to abiotic stress conditions. Transgenic tomato plants over expressing Evo133 demonstrated an increase of up to 25% under normal conditions, and up to 20% under abiotic stress conditions compared to control plants under the same conditions. Results from this third field trial are consistent with two previous field trials conducted in 2005 and 2006.

Back to news